05:10:25South Africa

DexCom, Inc. (DXCM)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
4,662,000,000 15.6%
Net income
836,300,000 45.1%
Gross profit
2,801,900,000
Operating income
911,800,000
Earnings per share
2.14 46.6%
R&D expense
599,100,000

Growth and profitability

Gross margin
60.10
Operating margin
19.56
Net margin
17.94
Return on equity
30.46
Return on assets
13.19
Free cash flow margin
23.11

Balance sheet

Total assets
6,339,900,000
Total liabilities
3,593,900,000
Shareholders' equity
2,746,000,000
Cash and equivalents
917,700,000
Current ratio
1.88

Cash flow and ratios

Operating cash flow
1,440,700,000
Free cash flow
1,077,200,000

Shareholder returns

Share buybacks
500,000,000
Shares outstanding
372,950,922
Book value per share
7.36
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
San Diego, CA
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Surgical & Medical Instruments & Apparatus

Fiscal year end: · Source: SEC EDGAR

DexCom, Inc. trades on NASDAQ under the ticker symbol DXCM. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis